Publications | Economic Analysis and Policy Division

Displaying 1 - 1 of 1

27 August 2020

The need to extend the WTO TRIPS pharmaceuticals transition period for LDCs in the COVID-19 era: Evidence from Bangladesh, by Daniel Gay and Kevin Gallagher (CDP Policy Review No. 10)

This policy brief synthesizes recent research, showing that Bangladesh?s vital pharmaceutical industry would be threatened if the country had to adhere fully to WTO rules upon graduation from LDC status.

Download